|Strategies for containing an emerging influenza pandemic in Southeast Asia|
NM Ferguson, DAT Cummings, S Cauchemez, C Fraser, S Riley, ...
Nature 437 (7056), 209-214, 2005
|Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections|
WHO Ebola Response Team
New England Journal of Medicine 371 (16), 1481-1495, 2014
|Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand|
N Ferguson, D Laydon, G Nedjati Gilani, N Imai, K Ainslie, M Baguelin, ...
|Estimates of the severity of coronavirus disease 2019: a model-based analysis|
R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ...
The Lancet infectious diseases, 2020
|Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions|
S Riley, C Fraser, CA Donnelly, AC Ghani, LJ Abu-Raddad, AJ Hedley, ...
Science 300 (5627), 1961-1966, 2003
|Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong|
CA Donnelly, AC Ghani, GM Leung, AJ Hedley, C Fraser, S Riley, ...
The Lancet 361 (9371), 1761-1766, 2003
|Factors that make an infectious disease outbreak controllable|
C Fraser, S Riley, RM Anderson, NM Ferguson
Proceedings of the National Academy of Sciences 101 (16), 6146-6151, 2004
|Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy|
MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ...
New England Journal of Medicine 379 (11), 1007-1016, 2018
|Large-scale spatial-transmission models of infectious disease|
Science 316 (5829), 1298-1301, 2007
|Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries|
S Flaxman, S Mishra, A Gandy, H Unwin, H Coupland, T Mellan, H Zhu, ...
|Modeling infectious disease dynamics in the complex landscape of global health|
H Heesterbeek, RM Anderson, V Andreasen, S Bansal, D De Angelis, ...
Science 347 (6227), 2015
|Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic|
RM Anderson, C Fraser, AC Ghani, CA Donnelly, S Riley, NM Ferguson, ...
Philosophical Transactions of the Royal Society of London. Series B …, 2004
|The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis|
AM Presanis, D De Angelis, A Hagy, C Reed, S Riley, BS Cooper, ...
PLoS Med 6 (12), e1000207, 2009
|Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe|
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...
Nature 584 (7820), 257-261, 2020
|Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility|
S Cauchemez, C Fraser, MD Van Kerkhove, CA Donnelly, S Riley, ...
The Lancet infectious diseases 14 (1), 50-56, 2014
|Global circulation patterns of seasonal influenza viruses vary with antigenic drift|
T Bedford, S Riley, IG Barr, S Broor, M Chadha, NJ Cox, RS Daniels, ...
Nature 523 (7559), 217-220, 2015
|The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients|
GM Leung, AJ Hedley, LM Ho, P Chau, IOL Wong, TQ Thach, AC Ghani, ...
Annals of internal medicine 141 (9), 662-673, 2004
|Reducing the impact of the next influenza pandemic using household-based public health interventions|
JT Wu, S Riley, C Fraser, GM Leung
PLoS Med 3 (9), e361, 2006
|Report 12: The global impact of COVID-19 and strategies for mitigation and suppression|
P Walker, C Whittaker, O Watson, M Baguelin, K Ainslie, S Bhatia, S Bhatt, ...
|Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA|
LF White, J Wallinga, L Finelli, C Reed, S Riley, M Lipsitch, M Pagano
Influenza and other respiratory viruses 3 (6), 267-276, 2009